Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara Silbert, Marlie R. M. Provost, Álex Bataller et al.|Blood|2025Cited by 33
Characterization of Extramedullary Disease (EMD) Response to CD19 Targeted Chimeric Antigen Receptor T-Cells (CART) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Multi-Site, Retrospective Cohort ReviewAlexander W. Rankin, Susan R. Rheingold, Regina M. Myers et al.|Transplantation and Cellular Therapy|2024Cited by 4
Initial Experience with CD19/CD22 BiCistronic CAR T-Cells in Children and Young Adults with Recurrent or Refractory B-Cell MalignanciesBrynn B. Duncan, Nirali N. Shah, Sara Silbert et al.|Blood|2024Cited by 4
Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic LeukemiaBrynn B. Duncan, Nirali N. Shah, Alexander W. Rankin et al.|Transplantation and Cellular Therapy|2025Cited by 0
CD19/22 CAR T-cells in children and young adults with B-ALL: Final Phase 1 trial resultsSara Silbert, Nirali Shah, Flavia Gava et al.|Blood|2025Cited by 0